Press Releases

MENLO PARK, Calif., Sept. 26, 2019 /PRNewswire/ -- Companies are going beyond providing traditional health benefits to address employees' well-being, finds a survey from global staffing firm Robert Half. In research conducted for the

MORRISTOWN, N.J., Sept. 26, 2019 /PRNewswire/ -- Currax Pharmaceuticals LLC, a specialty biopharmaceutical company with both Branded and generic business units, announced today a deal whereby Currax obtained patent rights to ONZETRA® Xsail® (sumatriptan nasal powder) in North America from OptiNose AS, a subsidiary of OptiNose, Inc

CAMBRIDGE, Mass. and NEW YORK, Sept. 26, 2019 /PRNewswire/ -- Black Diamond Therapeutics, Inc., a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, today announced that preclinical data defining the molecular mechanism for oncogenic activation of families of epidermal

BURLINGTON, Mass., Sept. 26, 2019 /PRNewswire/ -- Decision Resources Group (DRG), www.decisionresourcesgroup.com, a premier provider of data, analytics and insights pr

LOS ANGELES, Sept. 26, 2019 /PRNewswire/ -- Theragun LLC, the leader in percussive therapy, announced today that it has settled the lawsuits filed against Massage Guns and Alyne, claiming infri

Technology Leader Releases Groundbreaking Research Report Providing Unique Insight From Over 800,000 Real-Time Canadian Medical Cannabis Patient Outcomes  TORONTO, Sept. 26, 2019 /PRNewswire/ -

CUPERTINO, Calif., Sept. 26, 2019 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today that James E. Brown, Chief Executive Officer will be presenting at the Cantor Fitzgerald Global Health Care Conference, at the InterContinental New York Barclay Hotel on Friday, October 4, 2019 at

RENO, Nev., Sept. 26, 2019 /PRNewswire/ -- BlackRidge Technology International, Inc. (OTCQB: BRTI), a leading provider of next-generation cyber defense solutions, is

LEXINGTON, Mass., Sept. 26, 2019 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that James Dentzer, Chief Executive Officer of Curis, will present at the Cantor Fitzgerald Global Healthcare Conference on Thursday, October 3, 2019 at

SMITHS FALLS, ON and MONTREAL, Sept. 26, 2019 /PRNewswire/ - Spectrum Therapeutics ("Spectrum"), the medical division of Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) is pleased to announce a donation to the Fondation de l'Hôpital du Sacré-Coeur de Montreal (Montreal Sacre Coeur Hospital Foundation) to supp